200 likes | 373 Views
“Overview of Utz Lab” ITI Retreat at Chaminade PJ Utz, MD Associate Professor of Medicine March 11, 2007. Main Research Goals: Technology Development for Analysis of IMIDs: Autoantibody Profiling FACS-based Technologies Reverse Phase Arrays Micro and Nano Fluidics
E N D
“Overview of Utz Lab” ITI Retreat at Chaminade PJ Utz, MD Associate Professor of Medicine March 11, 2007
Main Research Goals: Technology Development for Analysis of IMIDs: Autoantibody Profiling FACS-based Technologies Reverse Phase Arrays Micro and Nano Fluidics Novel Detection (Carbon Nanotubes) Bioinformatics Antigen-Specific Therapy, Oligos Mouse Models of SLE, T1D Study of Human Materials
Disease Interests: CTDs T1D IBD Sclerosing Cholangitis Primary Biliary Cirrhosis ANCA+ Vasculitis Cancer Atherosclerosis Transplantation Pediatric SLE Education
Bead-Based Multiplexed Cytokine Assay Adapted from Luminex website tutorial
Interferon and TLR Signaling IFN-I (IFN-a, IFN-b) IFNAR1 IFNAR2 JAK1 TYK2 ssRNA P P STAT1 STAT1 STAT2 STAT2 TLR 7 dsDNA TLR 9 IRF-9 IRF-9 IFN-b, IFN-a isotypes IFN inducible genes ISRE IRFs
Produce arrays using a robotic microarrayer
ALL MICE WT vs. PBS WT vs. IRF-9 WT vs. STAT-1
Summary: Interferon Signaling in Mice • B cells from IRF9-/- and IFNAR2-/- mice express lower basal levels of TLR7 and fail to upregulate TLR7 in response to IFN-I. • Novel role for IFN-I in TLR-7 specific B cell responses and production of anti-RNP antibodies in vivo.
Cell Signaling in T Cell Leukemia Chan et al. , Blood, In Press
Phospho-Protein Flow Cytometry Perez and Nolan, Nature Biotechnology, 2002, 20:155
Signal Transduction Biosignatures Stratify AML Patients into Clinical Subgroups Irish et al, Cell, 2004, 118:217
Development of New Therapies Analysis of Existing Therapies Bench Bedside Bench Animal Patient Immune Models Materials Monitoring Core
Patient Sample Acquisition IRB 5 Clinics (Ritu Gupta) Trials Interdisciplinary Clinical Data, Outcome Measures Processing and Freezing Future Staff Additional Clinics, Backup New Clinics Processing by IMC Trials in Other Disciplines